BridgeMD
New treatment option for Sensorineural Hearing Loss
Official title Hearing Preservation in Cochlear Implantation Surgery
ClinicalTrials.gov ID: NCT07146841
What this study is testing
- What it's testing
- In order to preserve the residual hearing in patients with sensorineural hearing loss (SNHL) receiving a cochlear implant (CI), the insertion trauma to the delicate and microscopic structures of the cochlea needs to be minimized. The surgical procedure starts with the conventional mastoidectomy-posterior tympanotomy (MPT) approach to the middle ear, and is followed by accessing the cochlea, with either a cochleostomy (CO) or via the round window (RW).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Severe hearing loss, CI candidate
- 18 years of age or older
- normal function of middle ear (i.e. no acute middle ear infections)
- dutch language proficiency
- choice for Advanced Bionics implant
You likely can't join if
- prior otologic surgery in the implanted ear (excluding tympanostomy tube placement)
- inner ear malformation present in the ear to be implanted (i.e. ossification, Mondini malformation)
- retrocochlear pathology present in the auditory system to be implanted
- neurocognitive disorders
- sudden deafness
The study team makes the final eligibility decision.
Where it's taking place
- Utrecht, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Utrecht, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.